Tacrolimus - 0378-2045-01 - (Tacrolimus)

Alphabetical Index


Drug Information of Tacrolimus

Product NDC: 0378-2045
Proprietary Name: Tacrolimus
Non Proprietary Name: Tacrolimus
Active Ingredient(s): .5    mg/1 & nbsp;   Tacrolimus
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Tacrolimus

Product NDC: 0378-2045
Labeler Name: Mylan Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA090596
Marketing Category: ANDA
Start Marketing Date: 20120723

Package Information of Tacrolimus

Package NDC: 0378-2045-01
Package Description: 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-2045-01)

NDC Information of Tacrolimus

NDC Code 0378-2045-01
Proprietary Name Tacrolimus
Package Description 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-2045-01)
Product NDC 0378-2045
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Tacrolimus
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20120723
Marketing Category Name ANDA
Labeler Name Mylan Pharmaceuticals Inc.
Substance Name TACROLIMUS
Strength Number .5
Strength Unit mg/1
Pharmaceutical Classes Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA]

Complete Information of Tacrolimus


General Information